CNCR
Loncar Cancer Immunotherapy ETF
CNCR | NASDAQ
$9.02
+$0.14 (+1.58%)
At close: Sep 4, 2026, 4:00 PM
+1.58%
(1D)No price chart data available for 1D timeframe.
Key Statistics
Market Cap 7.04M
AVG Volume 7.48K
AUM 12.73M
NAV 13.68
1D Range
9.02 9.02
52W Range
9.02 9.02
About CNCR
The index is composed of the common stock of approximately 30 pharmaceutical or biotechnology companies identified by the fund's index provider, as having a high strategic focus on the development of ...
Asset Class Equity
Holdings 31
Inception Date Oct 14, 2015
Expense Ratio 0.79%
Domicile United States
ISIN US26922A8264
Provider Other
Website Fund Home Page
Top Sectors
| Sector | Weight |
|---|---|
| Healthcare | 96.58% |
| Financial Services | 3.29% |
| Cash & Others | 0.13% |
Dividends
Yield 0%| Ex-Div | Amount | Pay Date |
|---|---|---|
| Dec 29, 21 | $1.8533 | Dec 31, 21 |
| Dec 30, 20 | $0.2881 | Jan 4, 21 |
| Dec 28, 17 | $0.3502 | Jan 2, 18 |
| Dec 29, 15 | $0.1060 | Jan 4, 16 |
Add to Watchlist
Select watchlists to add or remove CNCR